SynthesisAdvances in therapy2024

Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.

Eduardo Mysler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.